Ophthalmic Therapeutic Innovation
Ophthalmic Therapeutic Innovation
  • Home
  • About OTI
    • Mission
    • Vision
    • History
    • Contact Us
  • Pipelines & Partners
  • Breakthrough Discovery
  • Glaucoma
  • Team
  • Publications
  • News
  • More
    • Home
    • About OTI
      • Mission
      • Vision
      • History
      • Contact Us
    • Pipelines & Partners
    • Breakthrough Discovery
    • Glaucoma
    • Team
    • Publications
    • News
  • Home
  • About OTI
    • Mission
    • Vision
    • History
    • Contact Us
  • Pipelines & Partners
  • Breakthrough Discovery
  • Glaucoma
  • Team
  • Publications
  • News

Hugh P. Cam PHD, MBA

Dr. Cam is OTI Vice President of Operations.  He has led many projects across disparate fields, from AI-diagnostic of autism to antibody engineering, Alzheimer's disease, aging, RNAi and epigenetics. He served previously as director of research and IP at Leveragen and senior project manager with Dr. Li-Huei Tsai group in the Picower Institute for Learning and Memory at MIT. 


He holds a PhD in Biochemistry/Genomics from Harvard University, an executive MBA from Quantic and a BS in Molecular Biology from the University of Texas at Austin.

Copyright © OTI 2025 -  All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept